| May 1, 2008 |
| May 2, 2008 |
| April 2008 |
| April 2010 (final data collection date for primary outcome measure) |
| Pancreatic leak [ Time Frame: Post-operative day 3 ] [ Designated as safety issue: No ] |
| Same as current |
| Complete list of historical versions of study NCT00671463 on ClinicalTrials.gov Archive Site |
- Peritoneal fluid analysis [ Time Frame: Daily ] [ Designated as safety issue: No ]
- Serum biochemical analysis [ Time Frame: Daily ] [ Designated as safety issue: No ]
- Clinical outcomes [ Time Frame: Daily ] [ Designated as safety issue: No ]
|
| Same as current |
| |
| Pancreatic Stent to Prevent Leak After Distal Pancreatectomy |
| Leak Elimination After Pancreatic Stenting, a Randomized Controlled Trial |
The purpose of this study is to investigate an intervention to prevent complications after pancreas surgery. The goal is to determine if placing a stent into the pancreatic duct before surgery will decrease or prevent leaking from the pancreatic duct after surgery. Leaks are common after pancreas surgery and can result in serious problems and post-operative pain. The study will compare two groups. One group will have the stent before surgery, and the other group will have standard pancreas surgery, no endoscopy, and no stent. |
| |
| |
| Interventional |
| Prevention, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment |
- Pancreatic Surgery
- Pancreatic Duct Stenting
- Pancreatic Cancer
- Distal Pancreatectomy
- Pancreatic Diseases
- Pancreatic Cyst
- Pancreatic Ducts
|
| Procedure: Pancreatic duct stenting |
- Experimental: Pre-operative pancreatic duct stenting
- No Intervention: Control group, no endoscopy and no stent pre-operatively
|
| |
| |
| Enrolling by invitation |
| 80 |
|
| April 2010 (final data collection date for primary outcome measure) |
Inclusion Criteria:
- Adult patients (greater than or equal to 18 years of age)
- Scheduled to undergo an elective laparoscopic or open distal pancreatectomy
- Willing to undergo pre-operative endoscopy
- Consenting to the procedure
Exclusion Criteria:
- Contraindication to abdominal surgery
- Contraindication to general anesthesia or distal pancreatectomy
- Contraindication to upper endoscopy or ERCP
- Prior history of gastric bypass or other abdominal surgery in whom the ampulla will not be accessible via routine ERCP
- Ongoing pancreatitis
- Pancreatic necrosis or abscess
- History of sphincter of Oddi dysfunction
- History of ERCP-induced pancreatitis
|
| Both |
| 18 Years and older |
| No |
| Contact information is only displayed when the study is recruiting subjects |
| United States |
| |
| NCT00671463 |
| William Brugge, MD / Director of Endoscopy, Massachusetts General Hospital |
| 2007P000965 |
| Massachusetts General Hospital |
| American Society for Gastrointestinal Endoscopy |
| Study Director: |
Field F Willingham, MD, MPH |
MGH |
|
| Study Director: |
Denise W Gee, MD |
MGH |
|
| Study Director: |
Sevdenur Cizginer, MD |
MGH |
|
| Principal Investigator: |
David W Rattner, MD |
MGH |
|
| Principal Investigator: |
William R Brugge, MD |
MGH |
|
|
| Massachusetts General Hospital |
| May 2008 |